Results 1 to 10 of about 279,219 (179)

Invasive Aspergillosis Among Lung Transplant Recipients During Time Periods With Universal and Targeted Antifungal Prophylaxis—A Nationwide Cohort Study

open access: yesJournal of Fungi (Basel, Switzerland), 2023
The optimal prevention strategy for invasive aspergillosis (IA) in lung transplant recipients (LTXr) is unknown. In 2016, the Danish guidelines were changed from universal to targeted IA prophylaxis. Previously, we found higher rates of adverse events in
Michael Perch   +2 more
exaly   +4 more sources

Antifungal prophylaxis in stem cell transplantation centers in Turkey [PDF]

open access: yesTurkish Journal of Hematology, 2011
OBJECTIVE: This study aimed to determine the current state of antifungal prophylaxis in Turkish stem cell transplantation (SCT) centers. METHODS: he were 38 active stem cell transplantation centers in Turkey, 28 of which were registered with the European
Hamdi Akan
doaj   +4 more sources

Prophylaxis of Antifungal Drugs against Systemic Fungemia induced by Oral Candidiasis in Mice

open access: yesCurrent Issues in Molecular Biology, 2023
Oral mucositis is highly prevalent among the elderly, for whom oral care is often difficult. Oral mucositis, such as candidiasis, can induce systemic fungemia.
Kazunori Ninomiya   +6 more
doaj   +2 more sources

Mold-Active Antifungal Prophylaxis in Pediatric Patients with Cancer or Undergoing Hematopoietic Cell Transplantation

open access: yesJournal of Fungi, 2023
Invasive fungal diseases (IFDs), in particular invasive mold infections, still pose considerable problems in the care of children and adolescents treated for cancer or undergoing hematopoietic cell transplantation.
Thomas Lehrnbecher   +2 more
doaj   +2 more sources

Antifungal prophylaxis of patients undergoing allogenetic hematopoietic stem cell transplantation in China: a multicenter prospective observational study

open access: yesJournal of Hematology & Oncology, 2016
Background Antifungal prophylaxis is currently regarded as the gold standard in situations with allo-genetic hematopoietic stem cell transplantation (allo-HSCT).
Lei Gao   +9 more
doaj   +2 more sources

Diagnosis and Antifungal Prophylaxis for COVID-19 Associated Pulmonary Aspergillosis

open access: yesAntibiotics, 2022
The COVID-19 pandemic has redemonstrated the importance of the fungal-after-viral phenomenon, and the question of whether prophylaxis should be used to prevent COVID-19-associated pulmonary aspergillosis (CAPA).
Armani M. Hawes, Nitipong Permpalung
doaj   +2 more sources

Nebulized Amphotericin B in Mechanically Ventilated COVID-19 Patients to Prevent Invasive Pulmonary Aspergillosis: A Retrospective Cohort Study

open access: yesCritical Care Explorations, 2022
IMPORTANCE:. Despite high mortality rates of COVID-19-associated pulmonary aspergillosis (CAPA) in the ICU, antifungal prophylaxis remains a subject of debate.
Max Melchers, MD   +9 more
doaj   +1 more source

Characteristics of antifungal utilization for hospitalized children in the United States

open access: yesAntimicrobial Stewardship & Healthcare Epidemiology, 2022
Objective: To characterize antifungal prescribing patterns, including the indication for antifungal use, in hospitalized children across the United States.
Lourdes Eguiguren   +7 more
doaj   +1 more source

Systemic antifungal strategies in allogeneic hematopoietic stem cell recipients hospitalized in french hematology units: a post-hoc analysis of the cross-sectional observational AFHEM study

open access: yesBMC Infectious Diseases, 2022
Background Invasive fungal diseases (IFD) remain a major complication of allogeneic hematopoietic stem cell transplantation (alloHSCT) and are associated with high mortality rates in patients receiving alloHSCT.
Mauricette Michallet   +5 more
doaj   +1 more source

Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study

open access: yesCritical Care, 2021
Background Coronavirus disease 19 (COVID-19)-associated pulmonary aspergillosis (CAPA) emerged as important fungal complications in patients with COVID-19-associated severe acute respiratory failure (ARF).
Stefan Hatzl   +17 more
doaj   +1 more source

Home - About - Disclaimer - Privacy